APA (7th ed.) Citation

Palomares-Alonso, F., González-González, A., Paz-González, A. D., Ortiz-Pérez, E., Martínez-Vázquez, A. V., García-Torres, I., . . . Rivera, G. (2025). In Vitro Evaluation of Esters of Quinoxaline-1,4-di- N- oxide Derivatives as New Antitaeniasis Agents and Their Inhibitory Activity Against Triosephosphate Isomerase. Pharmaceuticals (14248247), 18(3), 406. https://doi.org/10.3390/ph18030406

Chicago Style (17th ed.) Citation

Palomares-Alonso, Francisca, Alonzo González-González, Alma D. Paz-González, Eyra Ortiz-Pérez, Ana Verónica Martínez-Vázquez, Itzhel García-Torres, Gabriel López-Velázquez, Helgi Jung-Cook, and Gildardo Rivera. "In Vitro Evaluation of Esters of Quinoxaline-1,4-di- N- Oxide Derivatives as New Antitaeniasis Agents and Their Inhibitory Activity Against Triosephosphate Isomerase." Pharmaceuticals (14248247) 18, no. 3 (2025): 406. https://doi.org/10.3390/ph18030406.

MLA (9th ed.) Citation

Palomares-Alonso, Francisca, et al. "In Vitro Evaluation of Esters of Quinoxaline-1,4-di- N- Oxide Derivatives as New Antitaeniasis Agents and Their Inhibitory Activity Against Triosephosphate Isomerase." Pharmaceuticals (14248247), vol. 18, no. 3, 2025, p. 406, https://doi.org/10.3390/ph18030406.